CNC Centene Corp
Company Analysis
Latest News
π΄ Centene is trading 6.8% down today as post-earnings gains evaporate
Centene is trading 6.8% down now at $59.74 after a strong Q2 earnings report failed to hold initial gains. β’ The company beat estimates and raised full-year...
Centene Crushes Q2 Estimates and Raises Its Outlook β So Why Are Investors Heading for the Exits?
Shares shifted sharply as Centene Corp. dropped 9.1% in pre-market trading to $58.23 despite delivering a blowout second quarter this morning. The paradox β a...
π΄ Centene is trading 9.1% down today despite Q2 beat and raised guidance
Centene is trading 9.1% down at $58.23 as investors reassess the company's margin trajectory and updated guidance following its Q2 2026 earnings report. β’ The...
Centene's second quarter 2026 earnings crushed estimates, leading to a raised full-year outlook.
Centene reported second quarter 2026 total revenues of $53.6 billion and GAAP EPS of $2.19, significantly exceeding analyst expectations. The company's Health...
Centene Corp Q2 2026 Earnings Preview: What Analysts Expect on July 28, 2026
Centene Corporation is expected to report Q2 2026 revenue of $47.53 billion and earnings per share of $0.89, with its current price of $63.35 trading slightly...
Centene Shares Sink, Pressured by $1 Billion Medicaid Payment Freeze
Centene shares fell sharply on July 23, 2026, following new regulatory challenges to its Medicaid business. The Centers for Medicare & Medicaid Services...
Centene awards Cognizant $1 billion contract to automate healthcare operations
Centene Corp awarded a multi-year technology services contract to Cognizant. The deal is valued at more than $500 million and could potentially reach $1...
π’ Centene is trading 4% up today as UnitedHealth results lift healthcare sector
Centene is trading 4% up at $66.45, rebounding from recent weakness as strong UnitedHealth earnings boost sentiment across the managed care space. β’ The stock...
Centene faces membership risk, as new law doubles Medicaid eligibility checks
A 2025 federal law will require states to verify Medicaid eligibility every six months. This mandate doubles the current annual frequency for adults aged 19-64...
π’ Centene Surges 4.6% in Pre-Market on Analyst Upgrades and Strong Q1 2026 Performance
Centene is trading 4.6% up at $69.69 in pre-market, driven by recent analyst upgrades and a strong Q1 2026 earnings beat. The stock is rebounding after a sharp...
π΄ Centene is trading 7.8% down today on Medicaid cost pressure and sector-wide weakness
Centene is trading at $63.35 (-7.81%) as investors react to ongoing Medicaid cost pressure and broader healthcare-sector weakness. β’ The company remains under...
π΄ Centene is trading 4.4% down today on Medicaid cost concerns and geopolitical stress
Centene is trading at $65.72 (4.4% down) as Medicaid cost concerns and geopolitical stress weigh on the healthcare sector. β’ The decline extends recent...
Centene Secures Illinois Medicaid Renewal to Serve 596,000 Members
Centene Corporationβs subsidiary, Meridian Health Plan, secured a new four-year contract from the Illinois Department of Healthcare and Family Services. The...
Centene Mentioned in Sector-Wide Coverage of Rising Obamacare Premiums
Industry reports indicate potential significant increases in Obamacare premiums for 2027, impacting Centene Corporation. Insurers forecast rate hikes, with...
Centene Eyes 30% Upside, Driven by Medicaid Gains and 2026 Recovery
Cantor Fitzgerald reiterated its Overweight rating on Centene on Monday. A Seeking Alpha analysis simultaneously published a bullish thesis for the insurer....
π’ CNC extends move to 5.1% up
CNC is trading at $67.45, up 5.1% versus the comparison close of $64.19 during regular trading. This is a price-movement alert; no separate company-specific...
π’ CNC is trading 4.3% up today after strong Q1 2026 earnings beat and raised guidance fuel recovery
β’ Centene reported a strong Q1 2026 earnings beat, exceeding consensus expectations and raising its full-year 2026 adjusted EPS outlook to greater than...
π΄ CNC is trading 41.2% down today on a sharp managed-care sector selloff
CNC is trading at $38.12 (41.2% down) in after-hours trading as the managed-care sector faces intense selling pressure. * The move is driven by heightened...
π’ CNC is trading 4.2% up today amid a rotation into value and healthcare names
CNC is trading 4.2% up at $65.59, rebounding from recent weakness observed earlier this week. β’ There are no fresh company-specific headlines, earnings...
Centene Appoints Former JPMorgan Executive Lauren Tyler to Board of Directors
Centene Corporation announced the election of Lauren Tyler to its Board of Directors, effective June 19, 2026. The appointment expands the company's board from...